OpenURL Connection Search

Select item for more details and to access through your institution.

Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2009, v. 28, n. 3, p. 223, doi. 10.1007/s10096-008-0616-1
By:
- Fréalle, E.;
- Decrucq, K.;
- Botterel, F.;
- Bouchindhomme, B.;
- Camus, D.;
- Dei-Cas, E.;
- Costa, J.;
- Yakoub-Agha, I.;
- Bretagne, S.;
- Delhaes, L.
Publication type:
Article
Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi’s anemia.
Published in:
Bone Marrow Transplantation, 2000, v. 26, n. 2, p. 215, doi. 10.1038/sj.bmt.1702469
By:
- Yakoub-Agha, I;
- Damaj, G;
- Garderet, L;
- Bonnet, J;
- Devergie, A;
- Esperou, H;
- Ribaud, P;
- Socie, G;
- Gluckman, E
Publication type:
Article
French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry.
Published in:
British Journal of Haematology, 2024, v. 205, n. 3, p. 990, doi. 10.1111/bjh.19505
By:
- Ferment, B.;
- Lambert, J.;
- Caillot, D.;
- Lafon, I.;
- Karlin, L.;
- Lazareth, A.;
- Touzeau, C.;
- Leleu, X.;
- Moya, N.;
- Harel, S.;
- Perrot, A.;
- Bories, P.;
- Vincent, L.;
- Lamure, S.;
- Mohty, M.;
- Malard, F.;
- Manier, S.;
- Yakoub‐Agha, I.;
- Schiano De Colella, J.‐M.;
- Brisou, G.
Publication type:
Article
Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.
Published in:
Journal of Clinical Pharmacy & Therapeutics, 2011, v. 36, n. 2, p. 152, doi. 10.1111/j.1365-2710.2010.01166.x
By:
- des Champs-Bro, B.;
- Leroy-Cotteau, A.;
- Mazingue, F.;
- Pasquier, F.;
- François, N.;
- Corm, S.;
- Lemaitre, L.;
- Poulain, D.;
- Yakoub-Agha, I.;
- Alfandari, S.;
- Sendid, B.
Publication type:
Article
Conversion from mycophenoate mofetil to enteric-coated mycophenolate sodium (MYFORTIC) in a patient with graft-versus-host disease.
Published in:
2006
By:
- Kuhnowski F;
- Terriou L;
- Magro L;
- Jouet J;
- Yakoub-Agha I
Publication type:
Journal Article
Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1316, doi. 10.1038/bmt.2015.157
By:
- Detrait, M;
- Morisset, S;
- Chalandon, Y;
- Yakoub-Agha, I;
- Dufossé, F;
- Labalette, M;
- Top, I;
- Elsermans, V;
- Barraco, F;
- Quintela, A;
- Tedone, N;
- Michallet, M;
- Raus, N;
- Tiercy, J-M;
- Dubois, V
Publication type:
Article
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies.
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 1, p. 45, doi. 10.1038/bmt.2014.216
By:
- Pascal, L;
- Mohty, M;
- Ruggeri, A;
- Tucunduva, L;
- Milpied, N;
- Chevallier, P;
- Tabrizi, R;
- Labalette, M;
- Gluckman, E;
- Labopin, M;
- Yakoub-Agha, I
Publication type:
Article
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Published in:
Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 253, doi. 10.1038/bmt.2014.244
By:
- Detrait, M Y;
- Morisset, S;
- Peffault de Latour, R;
- Yakoub-Agha, I;
- Crocchiolo, R;
- Tabrizi, R;
- Bay, J-O;
- Chevalier, P;
- Barraco, F;
- Raus, N;
- Vigouroux, S;
- Magro, L;
- Mohty, M;
- Milpied, N;
- Blaise, D;
- Socié, G;
- Michallet, M
Publication type:
Article
Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 12, p. 1492, doi. 10.1038/bmt.2014.193
By:
- Gomez, E;
- Duléry, R;
- Langlois, C;
- Coiteux, V;
- Terriou, L;
- Magro, L;
- Gauthier, J;
- de Berranger, E;
- Duhamel, A;
- Yakoub-Agha, I
Publication type:
Article
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 887, doi. 10.1038/bmt.2014.72
By:
- Tucunduva, L;
- Ruggeri, A;
- Sanz, G;
- Furst, S;
- Socié, G;
- Michallet, M;
- Arcese, W;
- Milpied, N;
- Yakoub-Agha, I;
- Linkesch, W;
- Cornelissen, J;
- Mannone, L;
- Iori, A P;
- Ribera, J-M;
- Sanz, J;
- Montesinos, P;
- Purtill, D;
- Labopin, M;
- Gluckman, E;
- Mohty, M
Publication type:
Article
Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 756, doi. 10.1038/bmt.2014.31
By:
- Cahu, X;
- Chevallier, P;
- Clavert, A;
- Suarez, F;
- Michallet, M;
- Vincent, L;
- Vigouroux, S;
- Blaise, D;
- Mariette, C;
- Bilger, K;
- Robin, M;
- Yakoub-Agha, I;
- Peffault de Latour, R;
- Mohty, M
Publication type:
Article
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 864, doi. 10.1038/bmt.2014.82
By:
- Cunha, R;
- Loiseau, P;
- Ruggeri, A;
- Sanz, G;
- Michel, G;
- Iori, A P;
- Socié, G;
- Arcese, W;
- Picardi, A;
- Dias de Heredia, C;
- Rio, B;
- Locatelli, F;
- O'Brien, T A;
- Yakoub-Agha, I;
- Diaz, M A;
- Milpied, N;
- Bittencourt, H;
- Souza, M P;
- Aljurf, M;
- Charron, D
Publication type:
Article
Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 628, doi. 10.1038/bmt.2014.7
By:
- Nagler, A;
- Labopin, M;
- Berger, R;
- Bunjes, D;
- Campos, A;
- Socié, G;
- Kröger, N;
- Goker, H;
- Yakoub-Agha, I;
- Shimoni, A;
- Mohty, M;
- Rocha, V
Publication type:
Article
Donor-derived CD4+/CCR7+ T-cell partial selective depletion does not alter acquired anti-infective immunity.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 611, doi. 10.1038/bmt.2014.6
By:
- Choufi, B;
- Trauet, J;
- Thiant, S;
- Labalette, M;
- Yakoub-Agha, I
Publication type:
Article
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 671, doi. 10.1038/bmt.2014.4
By:
- Avivi, I;
- Canals, C;
- Vernant, J-P;
- Wulf, G;
- Nagler, A;
- Hermine, O;
- Petersen, E;
- Yakoub-Agha, I;
- Craddock, C;
- Schattenberg, A;
- Niederwieser, D;
- Thomson, K;
- Blaise, D;
- Attal, M;
- Pfreundschuh, M;
- Passweg, J;
- Russell, N;
- Dreger, P;
- Sureda, A
Publication type:
Article
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 361, doi. 10.1038/bmt.2013.186
By:
- Chevallier, P;
- Labopin, M;
- Milpied, N;
- Bilger, K;
- Socié, G;
- Yakoub-Agha, I;
- Michallet, M;
- Bulabois, C-E;
- Maury, S;
- Beguin, Y;
- Bay, J-O;
- Blaise, D;
- Maillard, N;
- Guillerm, G;
- Daguindeau, E;
- Raus, N;
- Mohty, M
Publication type:
Article
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.
Published in:
Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 24, doi. 10.1038/bmt.2013.120
By:
- Cunha, R;
- Loiseau, P;
- Ruggeri, A;
- Sanz, G;
- Michel, G;
- PaolaIori, A;
- Socié, G;
- Arcese, W;
- Picardi, A;
- Dias de Heredia, C;
- Rio, B;
- Locatelli, F;
- O'Brien, T A;
- Yakoub-Agha, I;
- Angel Diaz, M;
- Milpied, N;
- Bittencourt, H;
- Pedro Souza, M;
- Aljurf, M;
- Charron, D
Publication type:
Article
Enteral nutrition: a first option for nutritional support of children following allo-SCT?
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 9, p. 1191, doi. 10.1038/bmt.2011.248
By:
- Azarnoush, S;
- Bruno, B;
- Beghin, L;
- Guimber, D;
- Nelken, B;
- Yakoub-Agha, I;
- Seguy, D
Publication type:
Article
Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD.
Published in:
Bone Marrow Transplantation, 2011, v. 46, n. 10, p. 1374, doi. 10.1038/bmt.2010.300
By:
- Thiant, S;
- Labalette, M;
- Trauet, J;
- Coiteux, V;
- de Berranger, E;
- Dessaint, J-P;
- Yakoub-Agha, I
Publication type:
Article
Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.
Published in:
Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1546, doi. 10.1038/bmt.2010.13
By:
- Thiant, S.;
- Yakoub-Agha, I.;
- Magro, L.;
- Trauet, J.;
- Coiteux, V.;
- Jouet, J.-P.;
- Dessaint, J.-P.;
- Labalette, M.
Publication type:
Article
Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.
Published in:
2010
By:
- Delhaes, L.;
- Mraz, J.-C.;
- Fréalle, E.;
- Durand-Joly, I.;
- Magro, L.;
- Ajzenberg, D.;
- Dardé, M.-L.;
- Dei-Cas, E.;
- Yakoub-Agha, I.
Publication type:
Case Study
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.
Published in:
Bone Marrow Transplantation, 2008, v. 42, n. 11, p. 757, doi. 10.1038/bmt.2008.252
By:
- Magro, L.;
- Catteau, B.;
- Coiteux, V.;
- Bruno, B.;
- Jouet, J.-P.;
- Yakoub-Agha, I.
Publication type:
Article
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the SociétéFrançaise de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 2, p. 165, doi. 10.1038/sj.bmt.1704756
By:
- Mohty, M;
- Attal, M;
- Marit, G;
- Bulabois, C. E.;
- Garban, F.;
- Gratecos, N.;
- Rio, B.;
- Vernant, J. P.;
- Sotto, J. J.;
- Cahn, J. Y.;
- Blaise, D.;
- Jouet, J. P.;
- Facon, T.;
- Yakoub-Agha, I.
Publication type:
Article
Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 5, p. 531, doi. 10.1038/sj.bmt.1704381
By:
- Depil, S.;
- Deconinck, E.;
- Milpied, N.;
- Sutton, L.;
- Witz, F.;
- Jouet, J. P.;
- Damaj, G.;
- Yakoub-Agha,, I.
Publication type:
Article
Non-Hodgkin's lymphoma.
Published in:
Bone Marrow Transplantation, 2002, v. 30, n. 4, p. 229, doi. 10.1038/sj.bmt.1703625
By:
- Yakoub-Agha, I.;
- Fawaz, A.;
- Folliot, O.;
- Guillerm, G.;
- Quesnel, B.;
- Fenaux, P.;
- Bauters, F.;
- Jouet, J.P.;
- Morschhauser, F.
Publication type:
Article
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT.
Published in:
Leukemia (08876924), 2014, v. 28, n. 4, p. 779, doi. 10.1038/leu.2013.259
By:
- Ruggeri, A;
- Sanz, G;
- Bittencourt, H;
- Sanz, J;
- Rambaldi, A;
- Volt, F;
- Yakoub-Agha, I;
- Ribera, J M;
- Mannone, L;
- Sierra, J;
- Mohty, M;
- Solano, C;
- Nabhan, S;
- Arcese, W;
- Gluckman, E;
- Labopin, M;
- Rocha, V
Publication type:
Article
Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.
Published in:
Leukemia (08876924), 2012, v. 26, n. 6, p. 1211, doi. 10.1038/leu.2011.351
By:
- Spyridonidis, A;
- Labopin, M;
- Schmid, C;
- Volin, L;
- Yakoub-Agha, I;
- Stadler, M;
- Milpied, N;
- Socie, G;
- Browne, P;
- Lenhoff, S;
- Sanz, M A;
- Aljurf, M;
- Mohty, M;
- Rocha, V
Publication type:
Article
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.
Published in:
Leukemia (08876924), 2012, v. 26, n. 1, p. 73, doi. 10.1038/leu.2011.310
By:
- Mohty, B;
- El-Cheikh, J;
- Yakoub-Agha, I;
- Avet-Loiseau, H;
- Moreau, P;
- Mohty, M
Publication type:
Article
Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
Published in:
Leukemia (08876924), 2010, v. 24, n. 11, p. 1867, doi. 10.1038/leu.2010.200
By:
- Mohty, M.;
- Labopin, M.;
- Balère, M. L.;
- Socié, G.;
- Milpied, N.;
- Tabrizi, R.;
- Ifrah, N.;
- Hicheri, Y.;
- Dhedin, N.;
- Michallet, M.;
- Buzyn, A.;
- Cahn, J.-Y.;
- Bourhis, J.-H.;
- Blaise, D.;
- Raffoux, C.;
- Espérou, H.;
- Yakoub-Agha, I.
Publication type:
Article
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone.
Published in:
Leukemia (08876924), 2010, v. 24, n. 3, p. 623, doi. 10.1038/leu.2009.273
By:
- Avet-Loiseau, H;
- Soulier, J;
- Fermand, J-P;
- Yakoub-Agha, I;
- Attal, M;
- Hulin, C;
- Garderet, L;
- Belhadj, K;
- Dorvaux, V;
- Minvielle, S;
- Moreau, P
Publication type:
Article
A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy
Published in:
Leukemia (08876924), 2006, v. 20, n. 9, p. 1557, doi. 10.1038/sj.leu.2404308
By:
- Yakoub-Agha, I.;
- Saule, P.;
- Depil, S.;
- Micol, J.-B.;
- Grutzmacher, C.;
- Boulanger-Villard, F.;
- Bauters, F.;
- Jouet, J.-P.;
- Dessaint, J.-P.;
- Labalette, M.
Publication type:
Article
Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML.
Published in:
2005
By:
- Corm, S.;
- Biggio, V.;
- Roche-Lestienne, C.;
- Laï, J.-L.;
- Yakoub-Agha, I.;
- Philippe, N.;
- Nicolini, F.-E.;
- Facon, T.;
- Preudhomme, C.
Publication type:
Letter
Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL.
Published in:
Leukemia (08876924), 2003, v. 17, n. 10, p. 2056, doi. 10.1038/sj.leu.2403075
By:
- Dalle, J.H.;
- Leblond, P.;
- Decouvelacre, A.;
- Yakoub-Agha, I.;
- Preudhomme, C.;
- Neiken, B.;
- Mazingue, F.
Publication type:
Article
HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP.
Published in:
Hematological Oncology, 2019, v. 37, p. 299, doi. 10.1002/hon.108_2630
By:
- Bazarbachi, A.;
- Boumendil, A.;
- Finel, H.;
- Castagna, L.;
- Dominietto, A.;
- Blaise, D.;
- Diez‐Martin, J.;
- Tischer, J.;
- Gülbas, Z.;
- Labussière Wallet, H.;
- Lopez Corral, L.;
- Mohty, M.;
- Koc, Y.;
- Yakoub‐Agha, I.;
- Schmid, C.;
- Cheikh, J.;
- Arat, M.;
- Forcade, E.;
- Dreger, P.;
- Rocha, V.
Publication type:
Article
HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP.
Published in:
Hematological Oncology, 2019, v. 37, p. 299, doi. 10.1002/hon.108_2630
By:
- Bazarbachi, A.;
- Boumendil, A.;
- Finel, H.;
- Castagna, L.;
- Dominietto, A.;
- Blaise, D.;
- Diez‐Martin, J.;
- Tischer, J.;
- Gülbas, Z.;
- Labussière Wallet, H.;
- Lopez Corral, L.;
- Mohty, M.;
- Koc, Y.;
- Yakoub‐Agha, I.;
- Schmid, C.;
- Cheikh, J.;
- Arat, M.;
- Forcade, E.;
- Dreger, P.;
- Rocha, V.
Publication type:
Article
BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY.
Published in:
Hematological Oncology, 2017, v. 35, p. 83, doi. 10.1002/hon.2437_71
By:
- Bazarbachi, A.;
- Boumendil, A.;
- Finel, H.;
- Mohty, M.;
- Castagna, L.;
- Blaise, D.;
- Peggs, K.;
- Afanasyev, B.;
- Diez ‐ Martin, J.;
- Corradini, P.;
- Socié, G.;
- Robinson, S.;
- Gutiérrez ‐ García, G.;
- Bonifazi, F.;
- Yakoub ‐ Agha, I.;
- Gülbas, Z.;
- Bloor, A.;
- Delage, J.;
- Esquirol, A.;
- Malladi, R.
Publication type:
Article
REDUCED INTENSITY ( FB2) VS REDUCED TOXICITY MYELOABLATIVE ( FB3-4) FLUDARABINE/BUSULFAN-BASED CONDITIONING REGIMENS FOR NON- HODGKIN LYMPHOMA ( NHL) ALLOGRAFTED PATIENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 193, doi. 10.1002/hon.2438_55
By:
- Le Bourgeois, A.;
- Labopin, M.;
- Blaise, D.;
- Ceballos, P.;
- Vigouroux, S.;
- Peffault De Latour, R.;
- Suarez, F.;
- Bulabois, C.;
- Bay, J.;
- Chantepie, S.;
- Deconinck, E.;
- Daguindau, E.;
- Contentin, N.;
- Yakoub ‐ Agha, I.;
- Cornillon, J.;
- Francois, S.;
- Turlure, P.;
- Charbonnier, A.;
- Rohrlich, P.;
- N'Guyen, S.
Publication type:
Article

Found: 37

Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.

Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi’s anemia.

French early nationwide idecabtagene vicleucel chimeric antigen receptor T‐cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real‐world IFM study from the DESCAR‐T registry.

Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.

Conversion from mycophenoate mofetil to enteric-coated mycophenolate sodium (MYFORTIC) in a patient with graft-versus-host disease.

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.

Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies.

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Bone marrow graft as a source of allogeneic hematopoietic stem cells in patients undergoing a reduced intensity conditioning regimen.

Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC).

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome.

Donor-derived CD4<sup>+</sup>/CCR7<sup>+</sup> T-cell partial selective depletion does not alter acquired anti-infective immunity.

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.

Enteral nutrition: a first option for nutritional support of children following allo-SCT?

Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD.

Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse.

Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma genotyping to clinical management.

Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD.

Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the SociétéFrançaise de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)

Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.

Non-Hodgkin's lymphoma.

Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT.

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT.

Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agents.

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone.

A high proportion of donor CD4<sup>+</sup> T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy

Coexistence of AML1/RUNX1 and BCR-ABL point mutations in an imatinib-resistant form of CML.

Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow tranplantation for T-ALL.

HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP.

HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP.

BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY.

REDUCED INTENSITY ( FB2) VS REDUCED TOXICITY MYELOABLATIVE ( FB3-4) FLUDARABINE/BUSULFAN-BASED CONDITIONING REGIMENS FOR NON- HODGKIN LYMPHOMA ( NHL) ALLOGRAFTED PATIENTS.